ACHV Achieve Life Sciences, Inc. gains 16% Mar 22, 2019

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.http://www.priceseries.com/trade/ACHV-Achieve-Life-Sciences-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019031420190322.html